Each trading day, Benzinga Pro features hundreds of headlines and press releases, allowing traders to access the latest market news and individual stock information. Below is a look at its most-searched tickers for 2025, along with how interest in those names…
L3Harris Technologies, Inc. (NYSE:LHX) announced on Monday that it has agreed to sell a controlling interest in its Space Propulsion and Power Systems business to AE Industrial Partners, a private investment firm focused on aerospace and national security technologies. The…
Gold and silver prices surged this week as investors digested a combustible mix of geopolitics, monetary policy expectations, and long-term fiscal concerns, creating an environment increasingly reflected in precious metals ETFs. Spot gold jumped above $4,445.8 an ounce on Monday…
Neumora Therapeutics, Inc. (NASDAQ:NMRA) on Monday shared results from its Phase 1b signal-seeking study of NMRA-511 for Alzheimer’s disease (AD) agitation. NMRA-511 demonstrated a clinically meaningful effect size in people with AD agitation. In the study, NMRA-511 demonstrated a favorable…
Deep-pocketed investors have adopted a bullish approach towards Lam Research (NASDAQ:LRCX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such…
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) on Monday shared topline results from the fourth cohort of its Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant for CAH and adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome. CAH is a genetic disease that affects the…
In the current session, Aon Inc. (NYSE:AON) is trading at $342.07, after a 0.64% decrease. Over the past month, the stock fell by 0.32%, and in the past year, by 0.96%. With performance like this, long-term shareholders are more likely…
Oil ETFs directly tied to crude prices slipped on Monday, even as energy equity ETFs surged, underscoring a growing split between oil prices and oil stocks after the U.S. military intervened in Venezuela. Crude-linked funds such as the United States…
Constellation Brands, Inc. (NYSE:STZ) will release earnings results for the third quarter after the closing bell on Wednesday, Jan. 7, 2025. Analysts expect the company to report quarterly earnings at $2.64 per share, down from $3.25 per share in the…
Zenas BioPharma Inc. (NASDAQ:ZBIO) stock is trading lower on Monday after the company released results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD). IgG4-RD is an immune system disorder where the body creates excess IgG4…